BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 637042)

  • 1. Karyotypic abnormalities in precursor lesions of human cancer of the breast.
    Fisher ER; Paulson JD
    Am J Clin Pathol; 1978 Mar; 69(3):284-8. PubMed ID: 637042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.
    Jensen RA; Page DL; Holt JT
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9257-61. PubMed ID: 7937751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families.
    Petersson C; Pandis N; Mertens F; Adeyinka A; Ingvar C; Ringberg A; Idvall I; Bondeson L; Borg A; Olsson H; Kristoffersson U; Mitelman F
    Genes Chromosomes Cancer; 1996 Jul; 16(3):185-8. PubMed ID: 8814451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of benign breast lesions.
    Lundin C; Mertens F
    Breast Cancer Res Treat; 1998 Sep; 51(1):1-15. PubMed ID: 9877025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma.
    Niu Y; Wang S; Liu T; Zhang T; Wei X; Wang Y; Jiang L
    Pathol Res Pract; 2013 Apr; 209(4):221-7. PubMed ID: 23523041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.
    Ellsworth RE; Ellsworth DL; Weyandt JD; Fantacone-Campbell JL; Deyarmin B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2010 Jun; 17(6):1688-94. PubMed ID: 20107913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosome abnormalities and pathological mitoses in breast fibroadenomatosis and cancer].
    Neishtadt EL
    Vopr Onkol; 1974 Oct; 20(7):3-8. PubMed ID: 4408870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is fibrocystic disease precancerous?].
    De León Antoni E
    Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
    Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
    Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
    Mendelin J; Grayson M; Wallis T; Visscher DW
    Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.
    Marinho AF; Botelho M; Schmitt FC
    Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer precursors: lessons learned from molecular genetics.
    Sinn HP
    J Mol Med (Berl); 2009 Feb; 87(2):113-5. PubMed ID: 19139833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.